[HTML][HTML] A review of advances in the last decade on targeted cancer therapy using 177Lu: Focusing on 177Lu produced by the direct neutron activation route

R Chakravarty, S Chakraborty - American Journal of Nuclear …, 2021 - ncbi.nlm.nih.gov
Abstract Lutetium-177 [T½= 6.76 d; E β (max)= 0.497 MeV; maximum tissue range~ 2.5 mm;
208 keV γ-ray] is one of the most important theranostic radioisotope used for the …

Development of polyethylene glycol-modified gold nanoparticles for the delivery of Lutetium-177-radiopharmaceuticals based on antibodies

H Wongso, TS Humani, N Effendi… - Journal of Drug Delivery …, 2024 - Elsevier
Lutetium-177-labeled radiopharmaceuticals have been used clinically for the treatment of
various malignancies in nuclear medicine. The main characteristics of lutetium-177 (177 Lu) …

Preliminary Studies of 177Lu-Diethylenetriamine Penta-Acetic Acid-Deoxyglucose in Hepatic Tumor-Bearing Mice

L Zhou, L Chen, L Yang, L Cai, L Liu… - Cancer Biotherapy & …, 2020 - liebertpub.com
Objective: The purpose of this study was to explore the potential use of 177Lu-
diethylenetriamine penta-acetic acid-deoxyglucose (177Lu-DTPA-DG) as a …

[PDF][PDF] Development of a Thin Layer Chromatography method to determine the radiolabeling stability of PCL-PEO micelles radiolabeled with ¹⁷⁷Lu

WG Kerstjens - 2021 - repository.tudelft.nl
Polymeric micelles have a promising future in the treatment of cancer patients, and
particularly as carriers in chemotherapy. The effectiveness of the micelles can be …